Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D7PGM4
|
|||
Drug Name |
MK-4334
|
|||
Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
Company |
Merck
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03740178) A Randomized, Double-Blinded Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MK-4334 in Participants With Alzheimer's Clinical Syndrome on a Stable Dose of Donepezil. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.